India plans to vaccinate 300 million people by August, plans to export vaccines to 40 countries, and has signed a contract with the United States

The global epidemic is still serious. More than 110 million people have been infected with the new coronavirus. United Nations Secretary-General Guterres severely criticized the serious imbalance and unfairness of the COVID-19 vaccine, and pointed out that only 10 countries have been vaccinated. 75% of the vaccine.

India has nearly 11 million people infected with the new crown, making it the second most infected country in the world, although some experts believe that the most serious period has passed. COVAXIN is one of two vaccines that have been approved for emergency use in India, although efficacy data from its late-stage trials have not yet been announced. India is currently using COVAXIN for vaccination campaigns, which has already covered more than 9 million health workers, and plans to cover 300 million people by August.

India's Bharat Biotechnology Company said on the 17th that it is submitting documents to more than 40 countries and regions and is awaiting approval. It plans to export millions of doses of vaccine to Brazil, and also signed an agreement with the American biopharmaceutical company Ocugen Inc. to export the COVAXIN vaccine to the United States.